Pluristem Therapeutics Inc (PSTI)

[Straightshot]

How will the statistical difference in the distance walked between the placebo and our cells going to be determined... What is statistical difference in walking... 10 feet, 100 yards, 1/2 mile?... that seems, IMHO, to be an arbitrary primary efficacy point... plus... after one year and since most patients are 65+ years old, what if a certain number of patients develop other structural issues unrelated to IC such as hip or knee joint problems that affects the ability to walk... any consideration for these outliers that could change the result?... I believe we will demonstrate a benefit but will it be a statistical benefit by whatever criteria is utilized... good luck to investors and most of all to the human race...